Non-invasive Stimulation in Neurofibromatosis Type 1

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 13, 2017

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
Neurofibromatosis 1
Interventions
OTHER

Transcranial direct current stimulation

tDCS is an established research tool for non-invasive modulation of neuroplasticity. It has shown promise as a neurorehabilitation tool and demonstrated positive effects in various clinical conditions such as Alzheimer's, stroke, childhood psychosis, epilepsy and dystonias. tDCS uses low-intensity DC currents to modulate spontaneous neuronal network activity by altering the resting membrane potential.

Trial Locations (1)

M13 9QQ

University of Manchester, Manchester

All Listed Sponsors
lead

University of Manchester

OTHER

NCT03310996 - Non-invasive Stimulation in Neurofibromatosis Type 1 | Biotech Hunter | Biotech Hunter